Profile of Brazilian undergraduates who use electronic cigarettes: an epidemiological study on forbidden use

• Grant number: 21/05320-0
• Support Opportunities: Scholarships in Brazil - Scientific Initiation
• Start date: August 01, 2021
• End date: January 31, 2023
• Field of knowledge: Health Sciences - Collective Health - Public Health
• Principal Investigator: Lúcio Garcia de Oliveira
• Grantee: Gabriella dos Santos Maximino
• Host Institution: Centro Universitário FMABC (FMABC). Santo André , SP, Brazil

Abstract

In the last years, the use of e-cigarette has gained attention in the European and American continent, despite its creation dates 2003. In Brazil, in 2009, the Brazilian Health Regulatory Agency (ANVISA) restricted the sale, import, and advertising of products related to e-cigarettes; despite this regulation, the use of e-cigarettes continues to be carried out in Brazilian cities. Till now, we are not aware of studies that have identified the Brazilians who still engage in e-cigarette use, a knowledge gap that is more pronounced among youngsters. Objectives: to identify the prevalence of e-cigarette use in a convenience sample of undergraduate students, as well as their profiles. Materials and methods: this is a cross-sectional and observational study. A convenience sample of Brazilian undergraduates has been invited to remotely answer a structured research instrument on (a) demographics; (b) socieeconomic status, (c) academic data (d) health status, and (d) specifically, on the use of alcohol and other drugs, particularly e-cigarette use. The research instrument has been available through the "Survey Monkey" platform. Later, the data will be transferred to the STATA v12 and Minitab 18.1 programs in order to perform descriptive and inferential statistical analyses. Perspectives: this proposal is part of a nuclear study that started in March/21. We expect that the study data would guide the development of public policies in order to regulate the use of e-cigarettes in Brazil, where its use is theoretically forbidden. (AU)

Scientific publications

(6)

(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)

ROVERSI, FERNANDA MARCONI; PEREIRA BUENO, MAURA LIMA; FRANCISCO DA SILVA, JULIETE APARECIDA; ASSIS-MENDONCA, GUILHERME ROSSI; OLALLA SAAD, SARA TERESINHA. Optimized multiplex immunofluorescence for the characterization of tumor immune microenvironment in neoplastic paraffin-preserved tissues. JOURNAL OF CELL COMMUNICATION AND SIGNALING, v. 17, n. 3, p. 11-pg., 2023-05-16. (17/21801-2, 21/05320-0, 19/25247-5)

PEREIRA BUENO, MAURA LIMA; ARTICO, LEONARDO; SANTOS DUARTE, ADRIANA SILVA; BASSO, AUDREY; YUNES, JOSE ANDRES; SAAD, SARA T. OLALLA; ROVERSI, FERNANDA MARCONI. Combined Inhibition of MCL1 By AZD5991 and BCL2/Bclxl By AZD4320 As Promising Strategies to Overcome Acute Leukemia Tumor Burden and Niche Chemoresistance. Blood, v. 140, p. 2-pg., 2022-11-15. (17/21801-2, 21/05320-0, 19/25247-5)

ROVERSI, FERNANDA MARCONI; PEREIRA BUENO, MAURA LIMA; BASSO, AUDREY; SANTOS DUARTE, ADRIANA SILVA; SILVA, JULIETE A. F.; OLALLA SAAD, SARA T.. HCK Inhibition Displays Antineoplastic Activity on Acute Leukemia and Promotes Immune Regulation of the Bone Marrow Tumor Microenvironment. Blood, v. 140, p. 2-pg., 2022-11-15. (17/21801-2, 21/05320-0, 19/25247-5)

MAXIMINO, GABRIELLA DOS SANTOS; ANDRADE, ANDRE LUIZ MONEZI; DE ANDRADE, ARTHUR GUERRA; DE OLIVEIRA, LUCIO GARCIA. Profile of Brazilian Undergraduates Who Use Electronic Cigarettes: a Cross-Sectional Study on Forbidden Use. INTERNATIONAL JOURNAL OF MENTAL HEALTH AND ADDICTION, v. N/A, p. 14-pg., 2023-05-22. (21/05320-0)

BUENO, MAURA LIMA PEREIRA; SAAD, SARA TERESINHA OLALLA; ROVERSI, FERNANDA MARCONI. WNT5A in tumor development and progression: A comprehensive review. BIOMEDICINE & PHARMACOTHERAPY, v. 155, p. 18-pg., 2022-10-18. (19/25247-5, 17/21801-2, 21/05320-0)

BUENO, M. L. P.; FOGLIO, M.; SAAD, S. T. O.; ROVERSI, F. MARCONI. Tocotrienol exerts on-target malignant activity against leukemia. MOLECULAR BIOLOGY OF THE CELL, v. 34, n. 2, p. 2-pg., 2023-02-01. (17/21801-2, 21/05320-0, 19/25247-5)